Bristlecone Advisors, LLC Abiomed Inc Transaction History

Bristlecone Advisors, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 27, 2022	BUY	$242.49 - $301.46 $969 - $1,205	4 Added 0.19%	2,153 $529,000
Q2 2022 Jul 25, 2022	BUY	$224.73 - $338.64 $70,115 - $105,655	312 Added 16.98%	2,149 $532,000
Q1 2022 Apr 22, 2022	BUY	$277.25 - $366.29 $30,497 - $40,291	110 Added 6.37%	1,837 $608,000
Q4 2021 Jan 19, 2022	BUY	$300.63 - $371.35 $84,777 - $104,720	282 Added 19.52%	1,727 $620,000
Q3 2021 Oct 19, 2021	BUY	$310.19 - $376.2 $32,259 - $39,124	104 Added 7.76%	1,445 $470,000
Q2 2021 Jul 21, 2021	BUY	$262.71 - $351.17 $3,677 - $4,916	14 Added 1.06%	1,341 $419,000
Q1 2021 Apr 30, 2021	BUY	$285.92 - $355.13 $22,015 - $27,345	77 Added 6.16%	1,327 $423,000
Q4 2020 Jan 25, 2021	BUY	$251.88 - $324.2 $37,530 - $48,305	149 Added 13.53%	1,250 $405,000
Q3 2020 Oct 20, 2020	BUY	$255.22 - $317.0 $280,997 - $349,017	1,101 New	1,101 $305,000

137K

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

Get notified when there are updates to the investment portfolio of Bristlecone Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Bristlecone Advisors, LLC with notifications on news.